A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects

Objective: This study explored the bioequivalence of a proposed biosimilar HOT-3010 vs. its reference product (adalimumab) among healthy Chinese male subjects. The study also investigated the tolerance, immunogenicity, and pharmacokinetics (PK). Methods: A randomized, double-blind, two-arm, parallel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Zhang, Hong, Chen, Hong, Li, Xiaojiao, Wu, Min, Zhu, Xiaoxue, Li, Cuiyun, Liu, Jingrui, Wei, Haijing, Hu, Yue, Wang, Jingjing, Yang, Yongmin, Zhu, Xiangyang, Ding, Yanhua
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8190825/
https://ncbi.nlm.nih.gov/pubmed/34122068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.646171
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados